Loading page...
Loading page...
This round is closed. The next round and similar open calls are listed below. Synced from the EU Funding & Tenders Portal on 9 November 2026.
This call is closed. These open or upcoming calls fund the closest work.
Projects the EU funded under this call, with the organisation that led each one.
LESS MALNUTRITIONLOCAL, EQUITABLE, AND SUSTAINABLE SOLUTIONS FOR CHILD MALNUTRITION IN AFRICA
Led by Universiteit Gent · Belgium · 2026 · Official record ↗
NutriLOCDesigning Sustainable, Locally Sourced Supplementary and Therapeutic Foods for Emergency Nutrition
Led by Helsingin Yliopisto · Finland · 2026 · Official record ↗
Based on projects the EU funded on the same subject in this programme.
FOODITYFOod and nutritiOn Data-driven innovation respectful of citizen's Data SovereIgnTY
HORIZON-CL6-2022-GOVERNANCE-01-10 · 2023 · Official record ↗
NUTRICHECK-NETThe NUTRI-CHECK NETwork to maximise site-specific precision in managing the nutrition of European arable crops.
HORIZON-CL6-2022-GOVERNANCE-01-12 · 2023 · Official record ↗
BEETHOVENLinking Brain, Environment and Ecosystems Through Holistic Omics and Validated Evidence-based Nutrition guidelines
HORIZON-CL6-2025-02-FARM2FORK-12 · 2026 · Official record ↗
INNOECOFOODECO-INNOVATIVE TECHNOLOGIES FOR IMPROVED NUTRITION, SUSTAINABLE PRODUCTION AND MARKETING OF AGROECOLOGICAL FOOD PRODUCTS IN AFRICA
HORIZON-CL6-2023-FARM2FORK-01-19 · 2024 · Official record ↗
PROTEIN4IMPACTIMPACT OF ALTERNATIVE PROTEIN SOURCES TO IMPROVE NUTRITION
HORIZON-CL6-2024-FARM2FORK-01-7 · 2025 · Official record ↗
SPOONFood Systems in transition – ParticipatOry, Open citizen research for sustainable Nutrition
HORIZON-CL6-2024-FARM2FORK-01-6 · 2024 · Official record ↗
HealthyDiets4AfricaCombating Malnutrition in Africa Through Diversification of the Food System
HORIZON-CL6-2022-FARM2FORK-01-13 · 2023 · Official record ↗
NUTRITIVEINNOVATIVE DECISION-MAKING TOOL FOR DEFINING THE MOST SUITABLE MANURE MANAGEMENT STRATEGIES TO ACHIEVE A SUSTAINABLE LIVESTOCK FARMING SYSTEM DURING THE WHOLE VALUE CHAIN
HORIZON-CL6-2023-ZEROPOLLUTION-02-1-two-stage · 2024 · Official record ↗
Each one links to its EU funding record and the partners it works with: a starting list for building a consortium.
Ready-to-use Supplementary Food (RUSF) and Ready-to-use Therapeutic Food (RUTF) rely often on imported components while local resources are not exploited A sustainable and healthy food systems approach is needed for corrective action. Research and Innovation will increase the use of locally available sources of protein, micronutrients and fatty acids (plant-, marine-, and other locally available ingredients) in the local production and food processing of RUSF and RUTF, the latter in line with Codex Guidelines CXG 95-2022 in Africa. Identify options that allow for the safe use of new, locally produced, alternative supplementary foods to be certified by WHO and used, based on the health status of the child and the local conditions, as alternatives to the current ‘all RUTF’ approach. An approach that is more and more challenged by the increasing production and transportation costs, lack of access to beneficiaries, mainly in fragile and conflict affected countries and with a large carbon footprint.
The topic follows the Food 2030 approach, in particular its co-benefits on nutrition, climate, circularity and innovation and implements the FNSSA roadmap of the AU-EU research and innovation partnership. It is also part of a humanitarian-development-peace (HDP) nexus action.
Project results are expected to contribute to all the following expected outcomes:
In parallel research could be developed around new safe and efficacious, science based recipes that could complement and replace under specific circumstances, in collaboration with the Nutrition Technical Advisory Board and after the validation by WHO, the exclusive use of RUTF for persons not affected by severe acute malnutrition, while making sure that relevant quality criteria, information practices and use criteria are established (based on the child health status and local circumstances).
Research and innovation collaboration between Europe and Africa will help the African countries (health specialists, producers, seed companies, SMEs and food industries) to develop/ scale up the relevant and sustainable local production of RUSF and RUTF or any other types of supplements and related ingredients, using varieties adapted to local climate and agro-ecological conditions, thereby protecting and restoring biodiversity. Thereby contributing to reduce the climate footprint of production and transport in line with the objectives of climate change adaptation and mitigation and sustainable and efficient management of natural resources. Implement the multi-actor approach by involving a wide range of food systems actors and conducting inter-disciplinary research. Link up for clustering to other projects of the AU-EU research and innovation priorities, in particular linked to Food Systems transition projects and the wider range of projects in Food and Nutrition Security and Sustainable Agriculture (FNSSA), Climate Change and Sustainable Energy (CCSE) and the AU-EU Innovation Union using the network linkages to the CEA-First project and the International Research Consortium on FNSSA.
Innovation: Proposals should foresee a space for mentoring and accelerating innovative business concepts, including social innovation and upscaling in view of African or European food business entrepreneurs and start-ups with special consideration of women and the diaspora using cascading funding opportunities. Proposals should involve financial support to third parties e.g. to academic researchers, health institutes, start-ups, SMEs and other multidisciplinary actors, to, for instance, develop, test or validate developed assessment approaches or collect or prepare data sets or provide other contributions to achieve the project objectives. Consortia need to define the selection process of organisations, for which financial support will be granted. Maximum 20% of the EU funding can be allocated to this purpose. Proposals should involve contributions from the social sciences and humanities (SSH) disciplines.
1. Admissibility Conditions: Proposal page limit and layout
described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible Countries
described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other Eligible Conditions
The Joint Research Centre (JRC) may participate as member of the consortium selected for funding.
The following additional eligibility criteria apply: the proposals must apply the multi-actor approach. See definition of the multi-actor approach in the introduction to this work programme part.
The following additional eligibility criteria apply: due to the specific challenge of this topic, in addition to the minimum number of participants set out in the General Annexes, consortia must include at least three independent legal entities established in an African Union member state*. The places of establishment of at least two of these legal entities must be in the same region, as defined by the African Union: see https://au.int/en/member_states/countryprofiles2.
International organisations with headquarters in a Member State or Associated Country are exceptionally eligible for funding.
Due to the scope of this topic, legal entities established in all African Union member states* are exceptionally eligible for Union funding. * "African Union member states" includes countries whose membership has been temporarily suspended.
described in Annex B of the Work Programme General Annexes.
4. Financial and operational capacity and exclusion
described in Annex C of the Work Programme General Annexes.
5a. Evaluation and award: Award criteria, scoring and thresholds
are described in Annex D of the Work Programme General Annexes.
5b. Evaluation and award: Submission and evaluation processes
are described in Annex F of the Work Programme General Annexes and the Online Manual.
5c. Evaluation and award: Indicative timeline for evaluation and grant agreement
described in Annex F of the Work Programme General Annexes.
6. Legal and financial set-up of the grants
Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This decision is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf]].
Beneficiaries may provide financial support to third parties (FSTP). The support to third parties can only be provided in the form of grants. The maximum amount to be granted to each third party is EUR 60 000.
described in Annex G of the Work Programme General Annexes.
described in the [specific topic of the Work Programme]
Application and evaluation forms and model grant agreement (MGA):
Application form templates — the application form specific to this call is available in the Submission System
Standard application form (HE RIA, IA)
Evaluation form templates — will be used with the necessary adaptations 
Standard evaluation form (HE RIA, IA) 
Guidance
HE Programme Guide 
Model Grant Agreements (MGA)
Lump Sum MGA 
Call-specific instructions 
Detailed budget table (HE LS) 
Information on financial support to third parties (HE) 
Information on clinical studies (HE) 
Guidance: "Lump sums - what do I need to know?"
Additional documents:
HE Main Work Programme 2025 – 1. General Introduction
HE Main Work Programme 2025 – 9. Food, Bioeconomy, Natural Resources, Agriculture and Environment
HE Main Work Programme 2025 – 14. General Annexes
HE Programme Guide
HE Framework Programme 2021/695 
HE Specific Programme Decision 2021/764 
EU Financial Regulation 2024/2509
Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment 
EU Grants AGA — Annotated Model Grant Agreement 
Funding & Tenders Portal Online Manual 
Funding & Tenders Portal Terms and Conditions 
Funding & Tenders Portal Privacy Statement
Applicants asked the EU 4 questions about this call and the EU published the answers. They clarify the call documents but do not replace them.
Both options are possible. If you would choose an entity in another country of Southern or West Africa, it could give a more credible regional dimension to your proposal. This might be considered in the evaluation by the independent expert, when ranking excellent proposals.
Read it on the EU portal ↗Answered 13 Aug 2025
The WHO has several Technical Advisory Groups that provide expert advice on various health and nutrition topics. One example is the Technical Expert Advisory group on nutrition Monitoring (TEAM), which advises WHO and UNICEF on improving the quality of nutrition monitoring. The World Health Organization (WHO) validates Ready-to-Use Therapeutic Food (RUTF) through guidelines and recommendations, and inclusion on its Model List of Essential Medicines (EML). The WHO convened a guideline development group to evaluate the evidence on RUTF formulations, particularly those with reduced dairy or non-dairy options. While not a regulatory authority, UNICEF plays a significant role in RUTF validation by approving suppliers and products for procurement, especially in the absence of government oversight in some contexts.
Read it on the EU portal ↗Answered 2 Sept 2025
In the context of HE, Clinical study covers clinical studies/trials/investigations/cohorts and means any systematic prospective or retrospective collection and analysis of health data obtained from individual patients or healthy persons in order to address scientific questions related to the understanding, prevention, diagnosis, monitoring or treatment of a disease, mental illness, or physical condition. It includes but it is not limited to clinical trials as defined by Regulation 536/2014 (on medicinal products), clinical investigation and clinical evaluation as defined by Regulation 2017/745 (on medical devices), performance study and performance evaluation as defined by Regulation 2017/746 (on in vitro diagnostic medical devices). In the scope of this topic, clinical trials are not expected. However, for proposals containing clinical studies submitted to topics not foreseeing clinical studies, you may use the section headings of the clinical trial template as an orientation and provide the related information in sections B.1 and B.3 of the proposal.
Read it on the EU portal ↗Answered 13 Aug 2025
In the scope of this topic, clinical trials are not expected. However, as mentioned above, you may use the section headings of the clinical trial template as an orientation and provide the related information in sections B.1 and B.3 of the proposal. Beneficiaries may provide financial support to third parties (FSTP). Objectives and expected results must be clearly described in the proposal. Beneficiaries must include FSTP Annex in the application and upload it as separate annex to the proposal part B in the Submission System.
Read it on the EU portal ↗Answered 13 Aug 2025
Confirm the current call documents and submission conditions with the funding authority.
View on EU portal ↗Source: EU Funding & Tenders Portal · synced 2026-11-09
A free account keeps your shortlist and sends deadline reminders. The EUACC connector brings this call, its FAQs, past winners and similar calls into Claude or ChatGPT, so you can check fit and draft with sources.